Endoscopic Ultrasound-guided Coil With Cyanoacrylate Injection Versus Balloon-Occluded Retrograde Transvenous Obliteration in Managing Patients With Gastric Varices
NCT05500625 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2022-08-16
Summary
Gastrointestinal bleeding is a common complication of liver cirrhosis which caused by esophageal and gastric varices. The risk of bleeding from gastric varices is relatively low. However, the bleeding is usually significant and severe.
Current guidelines recommend endoscopic glue injection as the first line of treatment for gastric variceal bleeding.
Although this technique has been shown to be effective, it is associated with many severe adverse events including systemic embolization, fever, chest pain, and even death. The rate of hemostasis has been reported to be as high as 91-100% but the rebleeding rate from gastric varices still present.
Endoscopic ultrasound (EUS) guided therapy has recently been introduced as a more effective and safer option than endoscopic therapy for gastric varices. EUS-guided therapy includes EUS guided Cyanoacrylate injection alone or in combination with EUS-guided coiling. It offers the advantage of directly visualizing the varices and delivering targeted therapy.
A standard endoscopic examination only allows the evaluation of superficial varices. The use of Endoscopic ultrasound facilitates evaluation of peri-gastric and perforating vessels, which are directly involved in variceal development. EUS also facilitates accurate placement of the coil and preserves the naturally formed splenorenal shunt.
Balloon-occluded retrograde transvenous obliteration(BRTO) has been reported to achieve satisfactory bleeding control rates for isolated gastric varices with High hemostasis rates and low rebleeding rate.
Despite all these promising results, there are scarce studies describing and comparing the efficacy of EUS-guided therapy and BRTO in patients with gastric varices. Further prospective comparative studies are needed.
Conditions
- Gastric Varix
Interventions
- PROCEDURE
-
Endoscopic ultrasound-guided coil embolization combined with endoscopic cyanoacrylate injection
Standard diagnostic endoscopy will be done and Fundal varices will be assessed. EUS procedures will be performed using linear endoscope under general anesthesia. Use EUS to assess the anatomy of gastric varices, observe the blood flow, scan the portal venous system, left renal vein, confirm the location of the shunt, and measure the diameter of the shunt. Puncture the gastric fundal variceal vein at the lower esophagus near the cardia and place the coil into the shunt and immediately inject with sclerosant and cyanoacrylate under the guidance of EUS using a sandwich method (cyanoacrylate, sclerosant and cyanoacrylate) via endoscope. Use color Doppler ultrasound to observe the blood flow in the variceal veins to evaluate the embolization effect.
- PROCEDURE
-
Ballon-occluded retrograde transvenous obliteration
A balloon occlusion catheter will be inserted into the venous end of the gastro-renal or gastro-caval shunt via the right femoral vein or internal jugular vein. Balloon-occluded retrograde venogram will be done to evaluate degree of retrograde filling of the gastric varices and presence of collateral veins. Any significant large collateral veins seen will be occluded with coils using microcatheter to prevent leakage of the sclerosant into the systemic circulation. Then, sclerosant agent (ethanol-amine oleate, Sodium tetradecyl sulphate, or polidocanol) will be injected into the portosystemic shunt till complete filling of the gastric varices and part of the feeding veins. Finally, the balloon left in place for 2-12 hours then gradually will be deflated when complete occlusion of blood flow of the target shunt is achieved.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-30
- Primary Completion
- 2024-08-30
- Completion
- 2025-01-30
More Related Trials
-
Impact of EUS Guided Treatment of Gastric Varices
NCT05521685 ·Status: COMPLETED
-
Secondary Prophylaxis of Gastric Variceal Bleed
NCT02468206 ·Status: COMPLETED ·Phase: NA
-
SAFETY AND EFFICACY OF ENDOSCOPIC CONVENTIONAL CYANOACRYLATE GLUE VS EUS-GUIDED COIL PLUS CYANOACRYLATE TECHNIQUE IN THE TREATMENT OF GASTRIC VARICES: A RANDOMIZED CONTROLLED TRIAL
NCT05038319 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices
NCT05515861 ·Status: UNKNOWN ·Phase: NA
-
Primary Prophylaxis of Gastric Variceal Bleed
NCT02468180 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Endoscopic Injection of Conventional and Double Doses Cyanoacrylate for Gastric Variceal Hemorrhage
NCT00735358 ·Status: COMPLETED ·Phase: PHASE4
-
To Compare the Efficacy of Endoscopic Ultrasound Assisted Endoscopic Glue Injection and Conventional Endoscopic Injection Therapy for Prevention of Gastric Variceal Rebleed
NCT01631890 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety of EUS-Guided Therapy Versus BRTO for Gastric Varices With Shunt
NCT04828369 ·Status: COMPLETED
-
EUS Guided Coil Embolization for Primary Prophylaxis of Gastric Varices
NCT06370169 ·Status: RECRUITING ·Phase: NA
-
N-Butyl-2-Cyanoacrylate Injection Versus Band Ligation for Gastric Variceal Hemorrhage
NCT00292331 ·Status: COMPLETED ·Phase: PHASE3
-
EUS-guided Combined Therapy Versus Beta Blocker Therapy in Primary Prophylaxis o GOV II and IGV I
NCT04075760 ·Status: UNKNOWN ·Phase: NA
-
Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO
NCT02468167 ·Status: UNKNOWN ·Phase: NA
-
Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices
NCT05545475 ·Status: UNKNOWN
-
Primary Prevention of Gastric Varices Bleed
NCT05859009 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of Contrast EUS-Guided Tissue Glue/Coil Devascularization vs. BRTO for Preventing Recurrent Gastric Variceal Bleeding
NCT07049146 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Gastric Varices Treatment: Coil + Cyanoacrylate Versus Cyanoacrylate
NCT02115061 ·Status: UNKNOWN ·Phase: PHASE1
-
Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding
NCT02504723 ·Status: COMPLETED ·Phase: PHASE4
-
Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices
NCT00820781 ·Status: COMPLETED ·Phase: NA
-
Primary Prophylaxis of Gastric Varix Bleed
NCT00905996 ·Status: COMPLETED ·Phase: NA
-
N-butyl-2-cyanoacrylate, Iso-amyl-2-cyanoacrylate and Hypertonic Glucose With 72% Chromated Glycerin in Gastric Varices
NCT02330731 ·Status: COMPLETED ·Phase: NA
-
Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices
NCT06670157 ·Status: RECRUITING ·Phase: NA
-
To Compare the Safety and Efficacy of Balloon Occluded/Plug Assisted Retrograde Transvenous Obliteration With Endoscopic Variceal Obturation for Primary Prophylaxis of Gastric Varices With Large Spontaneous Shunt
NCT05677230 ·Status: COMPLETED ·Phase: NA
-
Time Interval for Endoscopic Variceal Ligation
NCT01291277 ·Status: COMPLETED ·Phase: PHASE4
-
Clip and Coil in Fundal Gastric Varices With a Large Shunt
NCT07263503 ·Status: COMPLETED
-
Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices
NCT01923064 ·Status: COMPLETED ·Phase: NA